Sector & Industry Research
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Stocks
Explore companies assigned to IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. Open a stock page for detailed price, fundamentals, technical indicators, forecasts and available filings.
COMPANY UNIVERSE
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES company directory
Sorted by available market capitalization. Missing values remain at the bottom; this is not an investment recommendation.
17stocks foundDatabase classification
Companies in IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Click a ticker or company to open its stock research page.
| Ticker | Company | Industry | Exchange | Market cap | Research |
|---|---|---|---|---|---|
| IDXX | Idexx Laboratories Inc | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $40,808,618,088 | Open research → |
| LNTH | Lantheus Holdings, Inc | In Vitro & In Vivo Diagnostic Substances | XNAS | $6,761,927,700 | Open research → |
| NEOG | Neogen Corp | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $2,586,926,503 | Open research → |
| CLDX | Celldex Therapeutics, Inc | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $2,300,915,288 | Open research → |
| NTLA | Intellia Therapeutics, Inc | In Vitro & In Vivo Diagnostic Substances | XNAS | $1,744,583,600 | Open research → |
| QDEL | QuidelOrtho Corporation | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $920,282,230 | Open research → |
| TKNO | Alpha Teknova, Inc. | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $474,604,095 | Open research → |
| MYGN | Myriad Genetics Inc | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $412,249,970 | Open research → |
| ACHV | Achieve Life Sciences, Inc. | In Vitro & In Vivo Diagnostic Substances | XNAS | $383,816,501 | Open research → |
| NNNN | Anbio Biotechnology | In Vitro & In Vivo Diagnostic Substances | XNAS | $203,511,623 | Open research → |
| IMDX | Insight Molecular Diagnostics Inc. | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $110,280,837 | Open research → |
| ICCC | Immucell Corp | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $89,005,531 | Open research → |
| BMRA | BIOMERICA INC | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $8,692,050 | Open research → |
| CDIO | Cardio Diagnostics Holdings Inc. | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $5,504,612 | Open research → |
| QCLS | Q/C Technologies, Inc. | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES | XNAS | $5,159,598 | Open research → |
| VRAX | Virax Biolabs Group Limited | In Vitro & In Vivo Diagnostic Substances | XNAS | $1,490,368 | Open research → |
| VNRX | VolitionRx Limited | In Vitro & In Vivo Diagnostic Substances | XASE | $1,454,324 | Open research → |
Classification reflects stored metadata. Market cap may be stale or unavailable. Not financial advice.